Researchers in Japan found that although the Alzheimer's drug lecanemab successfully removes amyloid plaques from the brain, it does not restore the brain's waste-clearing system within the first few months of treatment.
The study suggests that by the time symptoms appear, damage to nerve cells and the glymphatic system is already well established, making short-term recovery unlikely.
Lecanemab's Surprising Limits in Alzheimer's Treatment
Researchers at Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, reported that lecanemab, a drug designed to clear amyloid plaques from the brain, does not improve the brain's waste removal system in the early stages after treatment.
Their results indicate that the nerves of Alzheimer's disease (AD) patients have already sustained considerable damage, and that this waste-clearing function does not rebound quickly. The findings point to the need for treatments that target several biological problems at the same time.
The Complex Web of Alzheimer's Disease Mechanisms
The researchers' results add another piece to the long and complicated effort to understand how AD develops. Although it is the most widespread neurodegenerative disorder, it remains difficult to treat because many different factors contribute to its progression.
A major driver of nerve cell damage in AD is the accumulation of amyloid-β (Aβ) in the brain. In people without the disease, a network known as the glymphatic system circulates cerebrospinal fluid along the spaces surrounding arteries and into brain tissue. There, this fluid mixes with interstitial fluid to help remove metabolic waste products, including Aβ. The name "glymphatic system" comes from the involvement of glial cells in this process.
In AD, however, Aβ builds up and causes arteries to stiffen. This reduces the movement of fluid between the brain and the cerebrospinal fluid, which disrupts waste removal and leads to a series of harmful changes that produce AD symptoms.
Testing Lecanemab's Effects on Brain Clearance
Lecanemab, which was recently approved as a therapeutic option, is intended to lower Aβ levels. To study its effects, the Osaka Metropolitan University team examined the glymphatic system in patients both before and after lecanemab treatment, using the DTI-ALPS index to measure changes.
They found no meaningful difference in this index when comparing pre-treatment results with measurements taken three months after therapy.
What This Means for Future Alzheimer's Treatments
Based on these observations, the researchers concluded that while anti-amyloid drugs can reduce plaque buildup and slow additional cognitive decline, they may not be able to restore functions already lost. By the time symptoms appear, many patients likely have long-standing neuronal damage and glymphatic impairment that are difficult to reverse. The results emphasize how many interconnected factors drive AD and how few of them can be quickly repaired.
"Even when Aβ is reduced by lecanemab, impairment of the glymphatic system may not recover within the short-term," Oura said. "In the future, we want to look at factors like age, the stage of the disease, and degree of lesions in the white matter to further understand the relationship between changes in the glymphatic system due to lecanemab treatment and the outcome of treatment. This will help understand the best way to administer treatment to patients."
Reference: "Unchanged Early Diffusion Tensor Imaging Along Perivascular Space Index After Amyloid-Targeting Disease-Modifying Therapy in Alzheimer's Disease: A Preliminary Study" by Tatsushi Oura, Hiroyuki Tatekawa, Akitoshi Takeda, Ayako Omori, Natsuko Atsukawa, Shu Matsushita, Daisuke Horiuchi, Hirotaka Takita, Taro Shimono, Daiju Ueda, Yoshiaki Itoh and Yukio Miki, 8 September 2025, Journal of Magnetic Resonance Imaging.
DOI: 10.1002/jmri.70118
The study was published in Journal of Magnetic Resonance Imaging.
News
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
